EpidStrategies, a division of ToxStrategies, Inc., is excited to be participating in the European Hematology Association Virtual Congress, which will be held virtually from… read more
ToxStrategies is pleased to announce that John M. Rogers, Ph.D., has joined our Health Sciences Practice, following a distinguished career with the U.S…. read more
Ms. Mina Suh, along with colleagues within EpidStrategies (a Division of ToxStrategies), and external collaborators, has been conducting research on respiratory syncytial virus (RSV), especially as it relates to infants and children in the United States. In a prospective viral surveillance study, which was recently accepted… read more
The team of epidemiologists at EpidStrategies (a Division of ToxStrategies), along with colleagues in industry and academia, have been deeply involved in ongoing research on respiratory syncytial virus (RSV) in… read more
EpidStrategies, a division of ToxStrategies is excited to be participating in the American Society of Hematology Annual Meeting, which will be held virtually on December… read more
Dr. Naushin Hooda, an EpidStrategies Doctor of Pharmacy based in Toronto, will participate in a virtual panel discussion as part of the Canadian… read more
EpidStrategies scientists, including Dr. Jon Fryzek, Ms. Mina Suh, Ms. Heidi Reichert, Ms. Lauren Bylsma, Dr. Sarah Cohen, Ms. Xiaohui Jiang, and Ms…. read more
EpidStrategies scientists have collaborated with toxicologists from ToxStrategies’ Biopharmaceuticals/Pharmaceuticals Practice to produce a white paper that provides “Critical insights into nonclinical toxicology and… read more